PortfoliosLab logoPortfoliosLab logo
ISIN
KYG5966G1082
IPO Date
Feb 16, 2022

Highlights

Market Cap
$242.79M
Enterprise Value
$250.14M
EPS (TTM)
$0.58
PE Ratio
13.09
PEG Ratio
8.57
Total Revenue (TTM)
$183.80M
Gross Profit (TTM)
$61.75M
EBITDA (TTM)
$24.85M
Year Range
$7.36 - $63.28
ROA (TTM)
9.73%
ROE (TTM)
11.25%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Often compared with MHUA:
MHUA vs. GDE

Performance

MHUA Performance Chart

Meihua International Medical Technologies Co Ltd (MHUA) is up 0.0% since the beginning of the year. At $8 per share, MHUA is trading 88.0% below its 52-week high of $63.


Loading charts...

S&P 500 Index

Returns By Period

Meihua International Medical Technologies Co Ltd (MHUA) has returned 0.00% so far this year and -84.78% over the past 12 months.


Meihua International Medical Technologies Co Ltd

1D
0.00%
1M
0.00%
YTD
0.00%
6M
-34.51%
1Y
-84.78%
3Y*
-70.58%
5Y*
10Y*

Benchmark (S&P 500 Index)

1D
-0.74%
1M
4.90%
YTD
10.35%
6M
10.28%
1Y
26.52%
3Y*
20.83%
5Y*
12.30%
10Y*
13.66%
*Multi-year figures are annualized to reflect compound growth (CAGR)

MHUA Monthly Returns History

Based on dividend-adjusted daily data since Feb 16, 2022, MHUA's average daily return is -0.17%, while the average monthly return is -3.32%.

Historically, 32% of months were positive and 68% were negative. The best month was Feb 2023 with a return of +128.2%, while the worst month was Mar 2023 at -80.9%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 5 months.

On a daily basis, MHUA closed higher 42% of trading days. The best single day was Feb 21, 2023 with a return of +49.9%, while the worst single day was Dec 8, 2025 at -45.7%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20260.00%0.00%0.00%0.00%0.00%0.00%
2025-7.74%3.02%2.26%-18.01%65.47%-12.10%-5.20%10.73%-13.81%-35.59%-49.03%-35.94%-77.95%
2024-32.43%-29.52%4.71%-6.64%-4.95%30.09%19.73%-10.37%11.57%-33.33%-22.35%-34.64%-76.68%
202379.83%128.21%-80.90%-44.53%-23.33%3.26%-5.09%3.51%-36.79%-1.44%4.32%-18.68%-82.13%
2022-36.38%14.36%-11.70%-30.72%-7.83%-10.57%-19.83%57.89%28.33%74.42%-38.35%-35.91%

Benchmark Metrics

Meihua International Medical Technologies Co Ltd has an annualized alpha of -42.55%, beta of 0.84, and R2 of 0.01 versus S&P 500 Index. Calculated based on daily prices since February 17, 2022.

  • This stock participated in 195.45% of S&P 500 Index downside but only -117.67% of its upside - more exposed to losses than it benefited from rallies.
  • R2 of 0.01 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
-42.55%
Beta
0.84
0.01
Upside Capture
-117.67%
Downside Capture
195.45%

Return for Risk

Risk / Return Rank

MHUA ranks 4 for risk / return — in the bottom 4% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.


MHUA Risk / Return Rank: 44
Overall Rank
MHUA Sharpe Ratio Rank: 77
Sharpe Ratio Rank
MHUA Sortino Ratio Rank: 33
Sortino Ratio Rank
MHUA Omega Ratio Rank: 11
Omega Ratio Rank
MHUA Calmar Ratio Rank: 00
Calmar Ratio Rank
MHUA Martin Ratio Rank: 88
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Meihua International Medical Technologies Co Ltd (MHUA) and compare them to S&P 500 Index.


MHUABenchmarkDifference

Sharpe ratio

Return per unit of total volatility

-0.90

2.24

-3.14

Sortino ratio

Return per unit of downside risk

-1.94

3.07

-5.01

Omega ratio

Gain probability vs. loss probability

0.64

1.41

-0.77

Calmar ratio

Return relative to maximum drawdown

-1.03

2.93

-3.96

Martin ratio

Return relative to average drawdown

-1.41

13.52

-14.93

Dividends

Dividend History


Meihua International Medical Technologies Co Ltd doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Meihua International Medical Technologies Co Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Meihua International Medical Technologies Co Ltd was 99.80%, occurring on Dec 8, 2025. The portfolio has not yet recovered.

The current Meihua International Medical Technologies Co Ltd drawdown is 99.80%.


Related event

Drawdown

Fall

Recovery

Underwater

2025 bear market2025
-99.80%Dec 2025
2y 9mo
3y 3moFeb 2023 - now
Bear market2022
-79.87%Jul 2022
5mo 9d4mo 6d
9mo 15dFeb 2022 - Nov 2022
Bear market2022
-47.44%Dec 2022
29d1mo 3d
2mo 2dNov 2022 - Jan 2023
2023 correction2023
-19.75%Feb 2023
0s6d
6dFeb 2023 - Feb 2023
2023 pullback2023
-5.01%Feb 2023
4d1d
5dFeb 2023 - Feb 2023

Drawdown Indicators


MHUABenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-99.80%

-56.78%

-43.02%

Max Drawdown (1Y)

Largest decline over 1 year

-87.62%

-9.10%

-78.52%

Max Drawdown (3Y)

Largest decline over 3 years

-97.99%

-18.90%

-79.09%

Max Drawdown (5Y)

Largest decline over 5 years

-25.43%

Max Drawdown (10Y)

Largest decline over 10 years

-33.92%

Current Drawdown

Current decline from peak

-99.80%

-0.74%

-99.06%

Average Drawdown

Average peak-to-trough decline

-82.74%

-10.72%

-72.02%

Ulcer Index

Depth and duration of drawdowns from previous peaks

58.68%

1.97%

+56.71%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Meihua International Medical Technologies Co Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Meihua International Medical Technologies Co Ltd is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for MHUA, comparing it with other companies in the Medical Instruments & Supplies industry. Currently, MHUA has a P/E ratio of 13.1. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for MHUA compared to other companies in the Medical Instruments & Supplies industry. MHUA currently has a PEG ratio of 8.6. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for MHUA relative to other companies in the Medical Instruments & Supplies industry. Currently, MHUA has a P/S ratio of 1.3. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for MHUA in comparison with other companies in the Medical Instruments & Supplies industry. Currently, MHUA has a P/B value of 1.5. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with MHUA

Add Meihua International Medical Technologies Co Ltd to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with MHUA